Randomized Pilot Trial of the Impact of Bedside Delivery of Discharge Medications to Pediatric Patients With Asthma
1 other identifier
interventional
23
1 country
1
Brief Summary
This randomized pilot study proposes to field-test key logistical aspects of studying an intervention already available to patients on the pediatric ward, namely a discharge medication delivery service, called "Meds-in-Hand," which has been refined via a quality improvement process, but not rigorously studied nor fully implemented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Jan 2015
Shorter than P25 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 8, 2015
CompletedFirst Posted
Study publicly available on registry
January 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedOctober 30, 2015
October 1, 2015
4 months
January 8, 2015
October 28, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Experience measured by phone call followup interview
phone call followup interview to assess the patient experience
30 days
Study Arms (2)
Usual Care
NO INTERVENTIONdischarge medication prescriptions are printed or sent electronically to a patient's pharmacy of choice
Meds-in-Hand
ACTIVE COMPARATORdischarge medication delivery service: discharge prescriptions are filled at the hospital pharmacy and delivered to patients before they leave the hospital
Interventions
hospital-owned outpatient pharmacy fills and delivers discharge medications to patients in their rooms prior to discharge
Eligibility Criteria
You may qualify if:
- admission includes treatment for asthma exacerbation
- discharge medications will require a new prescription
- primary care taker speaks english or spanish
You may not qualify if:
- patients being discharge outside of the operating hours of the delivery service
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Hatoun, MD, MPH
Boston Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General Academic Pediatric Fellow
Study Record Dates
First Submitted
January 8, 2015
First Posted
January 13, 2015
Study Start
January 1, 2015
Primary Completion
May 1, 2015
Study Completion
July 1, 2015
Last Updated
October 30, 2015
Record last verified: 2015-10